🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Topchoice Medical Co., Inc. (SHA:600763)
China flag China · Delayed Price · Currency is CNY
34.03
-0.90 (-2.58%)
Nov 20, 2026, 9:45 AM CST

Topchoice Medical Co. Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
621.51501.95501500.44548.27702.81
Depreciation & Amortization
190.93190.93203.41189.35173.31153.8
Other Amortization
72.572.564.4555.2546.135
Loss (Gain) From Sale of Assets
0.270.27-0.14-0.050.02
Asset Writedown & Restructuring Costs
0.360.360.860.420.510.21
Loss (Gain) From Sale of Investments
-47.33-47.33-47.84-60.19-38.3-56.13
Provision & Write-off of Bad Debts
11.3511.353.171.751.671.29
Other Operating Activities
44.9122.82114.15131.85117.71109.25
Change in Accounts Receivable
-42.73-42.73-28.94-37.77-45.07-46.88
Change in Inventory
10.2210.22-3.74-1.9-2.55-2.68
Change in Accounts Payable
-3.78-3.78-37.371.22-122.1236.97
Change in Other Net Operating Assets
-1.64-1.64-1.64-1.64-1.64-1.64
Operating Cash Flow
852.36810.72762.99841.02670.05939.41
Operating Cash Flow Growth
-0.94%6.25%-9.28%25.52%-28.67%32.59%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-205.07-246.2-332.11-508.9-421.53-367.32
Sale of Property, Plant & Equipment
2.092.152.020.010.620.02
Cash Acquisitions
-540-15-27.73---
Divestitures
----0.03-131.95
Investment in Securities
3.3111.11-7.04-504.25-60.45-234.42
Other Investing Activities
-10.64-31.31-96.1-14.47-15.99-14
Investing Cash Flow
-750.31-279.24-324.97-887.63-497.35-483.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-5080280--
Long-Term Debt Repaid
--224.81-252.43-193.57-251.18-241.76
Lease Payments
-124.81-124.81-133.63-151.57-141.18-136.76
Net Debt Issued (Repaid)
46.19-174.81-172.4386.43-251.18-241.76
Repurchase of Common Stock
---30.1-1-99.99-
Common Dividends Paid
--208.89-149.89-11.24-6.69-12.87
Other Financing Activities
-107.67-71.32-59.85-63.04-28.33-31.3
Financing Cash Flow
-61.48-455.02-412.2811.15-386.19-285.93

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
40.5676.4625.74-35.46-213.5169.71

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
647.29564.52430.88332.13248.52572.09
Free Cash Flow Growth
9.63%31.02%29.73%33.64%-56.56%6.33%
Free Cash Flow Margin
21.56%19.38%14.99%11.67%9.14%20.57%
Free Cash Flow Per Share
1.451.260.960.740.551.27
Levered Free Cash Flow
435.15330.95375.96331.44-199.6365.3
Unlevered Free Cash Flow
454.96353.36404.36365.82-168.32383.37
Free Cash Flow After Leases
522.47439.71297.24180.56107.33435.33

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
164.13153.52162.07142.52227.01105.67
Change in Working Capital
-42.12-42.12-76.0622.15-179.26-6.83